The reduction or deletion of XOR in tumor cells leads to decreased LC survival [24].Low XOR expression is associated with poor differentiation of breast, gastric, and colorectal cancers, increasing their risk of distant metastasis by more than two-fold [25].While, the inhibition or deletion of XOR increases the invasiveness of breast cancer cells [26]. This evidence concerns the gene XDH and colorectal cancer.